Stanford University
Showing 171-180 of 510 Results
-
Patrick David Hsu
Assistant Professor of Pathology
BioPatrick Hsu is Co-Founder of the Arc Institute and Assistant Professor of Pathology at Stanford University. The Hsu lab works at the intersection of biology and machine learning to develop technologies for biological and therapeutic design. Recent contributions include the Evo series of genome foundation models and the first universally programmable DNA recombinases. Patrick received A.M. and Ph.D. degrees from Harvard University and the Broad Institute of MIT and Harvard, where he was an early pioneer of CRISPR-Cas9 technologies for genome editing. His research has been recognized by awards from the New York Times, The Atlantic, Forbes, MIT Technology Review, Vox, Rainwater Foundation, and Amgen. He serves on the scientific advisory board of Amgen and the board of Stylus Medicine, and cofounded Fast Grants for rapid science funding.
-
Rongting Huang
Postdoctoral Scholar, Pathology
BioDr. Huang is a computational biologist with academic interests in cancer genomics and spatial biology, particularly in the field of gynecologic cancers. During her Ph.D. under the mentorship of Dr. Yuanhua Huang, she developed statistical methods to detect allele-specific somatic copy number variations from single-cell and spatial transcriptomic data, aiming to understand genetic diversity in biological systems. Currently, her research focuses on advancing gynecologic cancer studies and women’s health through spatial technology platforms, computational modeling, and innovative data visualizations to uncover meaningful insights.
Outside of research, she enjoys hiking, rock climbing, and calligraphy, which help her stay creative and balanced. -
Peter K. Jackson
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
Current Research and Scholarly InterestsDr. Jackson’s lab studies how primary cilia organize hormone, metabolite, and growth factor signaling in metabolic tissues and how their disruption causes obesity and diabetes. A second focus is defining the KRAS driven secreted factor networks that rewire the tumor microenvironment in lung and pancreatic cancers to promote immune evasion and therapeutic resistance. This work is revealing new secreted drug targets and combination strategies for precision oncology and metabolic disease.
-
Siddhartha Jaiswal
Associate Professor of Pathology
Current Research and Scholarly InterestsWe identified a common disorder of aging called clonal hematopoiesis of indeterminate potential (CHIP). CHIP occurs due to certain somatic mutations in blood stem cells and represents a precursor state for blood cancer, but is also associated with increased risk of cardiovascular disease and death. We hope to understand more about the biology and clinical implications of CHIP using human and model system studies.
-
Iman Jaljuli
Postdoctoral Scholar, Pathology
BioPhD in Statistics,
Tel-Aviv University -
Olena Janczewski
Associate Director of Education, Pathology Ops Business Office
Current Role at StanfordAssociate Director of Education, Pathology
